212 related articles for article (PubMed ID: 3237706)
21. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
Valdes-Camin R; Callahan JB; Ebert RF
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
[TBL] [Abstract][Full Text] [Related]
22. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
Ts'ao C; Swedlund J; Neofotistos D
Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
[TBL] [Abstract][Full Text] [Related]
23. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
[TBL] [Abstract][Full Text] [Related]
24. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
McGlasson DL
Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
[TBL] [Abstract][Full Text] [Related]
25. Reference materials and reference measurement systems in laboratory medicine. Prothrombin time standardization: the problem of the control plasma.
D'Angelo A
Eur J Clin Chem Clin Biochem; 1995 Dec; 33(12):1019-22. PubMed ID: 8845419
[TBL] [Abstract][Full Text] [Related]
26. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
28. Prothrombin time standardisation in canine samples with regard to inter-batch and inter-reagent variability.
Mischke R
Vet J; 2011 Jun; 188(3):301-6. PubMed ID: 20655250
[TBL] [Abstract][Full Text] [Related]
29. Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio.
van den Besselaar AM; Houbouyan-Reveillard LL; Aillaud MF; Denson KW; Droullé C; Johnston M; Kitchen S; Lindahl TL; Marren M; Martinuzzo ME; Tripodi A; Vergnes C
Thromb Haemost; 1999 Nov; 82(5):1451-5. PubMed ID: 10595637
[TBL] [Abstract][Full Text] [Related]
30. The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems.
Poller L; Barrowcliffe TW; van den Besselaar AM; Jespersen J; Tripodi A; Houghton D
Thromb Haemost; 1998 Jan; 79(1):122-8. PubMed ID: 9459336
[TBL] [Abstract][Full Text] [Related]
31. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
Loeliger EA; van den Besselaar AM; Lewis SM
Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
[TBL] [Abstract][Full Text] [Related]
32. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
33. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.
Bailey EL; Harper TA; Pinkerton PH
Can Med Assoc J; 1971 Nov; 105(10):1041-3 passim. PubMed ID: 5150206
[TBL] [Abstract][Full Text] [Related]
34. [Prothrombin time and its standardization: a potentiality to introduce INR method in criteria for disseminated intravascular coagulation].
Kagawa K; Fukutake K
Rinsho Byori; 2002 Mar; 50(3):277-82. PubMed ID: 11985056
[TBL] [Abstract][Full Text] [Related]
35. A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem
Gardiner C; Kohama K; Patel I; Lane P; Dwyer S; Machin SJ; Mackie IJ
Int J Lab Hematol; 2017 Oct; 39(5):532-538. PubMed ID: 28603894
[TBL] [Abstract][Full Text] [Related]
36. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
van den Besselaar AM
Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
[TBL] [Abstract][Full Text] [Related]
37. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
38. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
Adcock DM; Johnston M
Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
[TBL] [Abstract][Full Text] [Related]
40. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
